Morepen Laboratories share news, announcements and annual reports
NSE: MOREPENLABBSE: 500288Pharmaceuticals & BiotechnologySmall Cap
Morepen Laboratories Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1993 on BSE, Nov 1999 on NSE
Last close ₹107.69down ₹5.66 (4.99%)BSE ₹108.05
Share price at the NSE close on 2 Nov 2026. Previous close ₹113.35.
2 Nov: open ₹107.69, high ₹107.69, low ₹107.69
52-week range of traded prices to 2 Nov 2026
₹33.05Low, 30 Mar 2026₹150.70High, 7 Oct 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 2 Nov 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,901 Cr1,108th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.30
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.19%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.22
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 8,39,229
Morepen Laboratories orders, deals and press releases
90 filed, newest first. Page 2 of 2.
Jul 2021
Jun 2021
13 Jun · Business
May 2021
4 May · Business
Apr 2021
Feb 2021
Nov 2020
Aug 2020
Jun 2020
Apr 2020
Feb 2020
Nov 2019
Oct 2019
Sep 2019
19 Sep · Business
Aug 2019
May 2019
Jul 2018
May 2018
Jan 2018
Dec 2017
Nov 2017
Apr 2017
Feb 2017
Nov 2016
Aug 2016
May 2016
Feb 2016
Nov 2015
May 2013
Jul 2011
Feb 2011
Sep 2007
20 Sep · Business
"The Company has entered into Agreements with G L India Mauritius III Ltd., a subsidiary of Avenue Capital Group (Investor), for subscribing Equity Shares and Naked Warrant to the tune of 14.99% and 5% respectively of the Equity Share Capital of the Company. The Company shall now proceed to issue and allot Equity Shares and Naked Warrants convertible into Equity Shares in due course on receipt of the subscription money and after necessary formalities". Further, the Company has issued a detailed press release in context of the execution of above referred agreement, dated September 20, 2007, titled "Morepen Signs Equity Deal With Avenue - Will Pay Off All CDR Banks". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2007
5 Jun · Business
Press release titled "Morepen starts Debt Settlement; Issues Fresh Capital of Rs.103 crores". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.